LEO Pharma A/S

Winner 2012

The Growth Strategy of the Year Award

LEO Pharma develops, manufactures and markets pharmaceutical drugs, primarily to treat dermatological conditions.  Over the past two years, the company has implemented an ambitious growth strategy with a more global and patient-centric focus. It has set up 11 international affiliates in key international markets, including the US which now accounts for 20% of total Group net sales. 

Sponsors & Supporters